U.S. Physical Therapy, Inc. (NYSE:USPH) CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $68.68, for a total value of $137,360.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Lawrance W. Mcafee also recently made the following trade(s):

  • On Wednesday, November 8th, Lawrance W. Mcafee sold 5,200 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $66.37, for a total value of $345,124.00.
  • On Friday, November 3rd, Lawrance W. Mcafee sold 800 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $69.21, for a total value of $55,368.00.

Shares of U.S. Physical Therapy, Inc. (USPH) traded up $1.00 during mid-day trading on Friday, hitting $68.50. The stock had a trading volume of 42,900 shares, compared to its average volume of 58,278. The firm has a market cap of $859.30, a PE ratio of 32.71, a PEG ratio of 2.91 and a beta of 1.07. The company has a current ratio of 2.04, a quick ratio of 2.04 and a debt-to-equity ratio of 0.30. U.S. Physical Therapy, Inc. has a fifty-two week low of $56.50 and a fifty-two week high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.04). The business had revenue of $103.03 million during the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. research analysts expect that U.S. Physical Therapy, Inc. will post 2.07 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 8th. Investors of record on Friday, November 17th will be issued a $0.20 dividend. The ex-dividend date of this dividend is Thursday, November 16th. This represents a $0.80 dividend on an annualized basis and a yield of 1.17%. U.S. Physical Therapy’s payout ratio is 57.97%.

COPYRIGHT VIOLATION WARNING: “Lawrance W. Mcafee Sells 2,000 Shares of U.S. Physical Therapy, Inc. (USPH) Stock” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/17/lawrance-w-mcafee-sells-2000-shares-of-u-s-physical-therapy-inc-usph-stock.html.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in USPH. Pinebridge Investments L.P. raised its holdings in U.S. Physical Therapy by 1.0% in the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after purchasing an additional 17 shares during the period. State of Alaska Department of Revenue raised its holdings in U.S. Physical Therapy by 77.8% in the 2nd quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after purchasing an additional 1,074 shares during the period. Sei Investments Co. raised its holdings in U.S. Physical Therapy by 31.8% in the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock worth $155,000 after purchasing an additional 622 shares during the period. SG Americas Securities LLC acquired a new position in U.S. Physical Therapy in the 3rd quarter worth about $170,000. Finally, Municipal Employees Retirement System of Michigan raised its holdings in shares of U.S. Physical Therapy by 3.1% during the second quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock valued at $178,000 after acquiring an additional 90 shares during the last quarter. 93.96% of the stock is owned by institutional investors.

Several analysts have weighed in on USPH shares. Cantor Fitzgerald started coverage on U.S. Physical Therapy in a research note on Monday, July 24th. They set an “overweight” rating and a $72.00 price target on the stock. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price target on the stock in a research note on Tuesday, August 29th. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $62.00 to $74.00 in a research note on Friday, September 8th. BidaskClub upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Finally, Barrington Research cut U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a report on Friday, November 3rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. U.S. Physical Therapy has a consensus rating of “Hold” and an average price target of $69.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.